RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS

Clinical trials for RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS explained in plain language.

Never miss a new study

Get alerted when new RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS trials appear

Sign up with your email to follow new studies for RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists track patients for years after pioneering HIV gene treatment

Disease control Ongoing

This study is monitoring 11 people who previously received an experimental gene therapy for HIV. The goal is to check for any long-term safety issues that might appear years after their treatment. Researchers are watching the patients' health and tracking the modified cells in th…

Matched conditions: RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS

Sponsor: Calimmune, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS

Get alerted when new RECEIPT OF CAL-1 MODIFIED HEMATOPOIETIC CELLULAR PRODUCTS trials appear

Scientists track patients for years after pioneering HIV gene treatment